By staff writers

March 13, 2009 -- Orbital Therapy of Bedford, MA, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ClearVue prone position breast radiotherapy treatment table.

Designed to simulate and treat breast cancer patients in the prone position, the carbon fiber add-on treatment table can be used with CT simulators and linear accelerators to plan and deliver radiation treatments.

Orbital Therapy debuts breast table, February 27, 2009

Copyright © 2009


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking